𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer

✍ Scribed by Toi, M; Bando, H; Horiguchi, S; Takada, M; Kataoka, A; Ueno, T; Saji, S; Muta, M; Funata, N; Ohno, S


Book ID
109998077
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
143 KB
Volume
90
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Future prospects of neoadjuvant chemothe
✍ Hwei-Chung Wang; Su-Shun Lo πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 689 KB

Neoadjuvant chemotherapy in breast cancer was developed in the 1970s and is now used in patients with locally advanced or early resectable breast cancer. Early administration of systemic chemotherapy before local treatment in locally advanced breast cancer and early resectable breast cancer is inten

Can the hormonal receptor status of prim
✍ Su-Shun Lo; Hwei-Chung Wang; Yi-Ming Shyr; Wing-Yiu Lui πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 201 KB

In order to know whether neoadjuvant chemotherapy would change the hormonal receptor status of primary breast cancer, 10 patients with locally advanced breast cancer treated with neoadjuvant CEF (endoxan , epirubicin, 5-fluorouracil) were studied. Tissue was obtained by incisional biopsy before chem

The dual role of thymidine phosphorylase
✍ Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 757 KB

## Abstract Thymidine phosphorylase (TP), also known as β€œplatelet‐derived endothelial cell growth factor” (PD‐ECGF), is an enzyme, which is upregulated in a wide variety of solid tumors including breast and colorectal cancers. TP promotes tumor growth and metastasis by preventing apoptosis and indu